Published in World J Immunol on March 27, 2014
The Skin Microbiome: Is It Affected by UV-induced Immune Suppression? Front Microbiol (2016) 0.78
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model. Cell Mol Immunol (2015) 0.78
T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? Photochem Photobiol Sci (2015) 0.77
Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives. Oxid Med Cell Longev (2016) 0.75
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) (2017) 0.75
Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy. Sci Rep (2016) 0.75
Panchromatic Osmium Complexes for Photodynamic Therapy: Solutions to Existing Problems and New Questions. Photochem Photobiol (2017) 0.75
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
Photodynamic therapy for cancer. Nat Rev Cancer (2003) 8.00
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1993) 6.47
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1994) 5.03
Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood (2004) 5.02
Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol (2011) 4.29
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med (1994) 4.20
Photoradiation therapy for the treatment of malignant tumors. Cancer Res (1978) 4.01
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med (1994) 3.94
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer (2006) 3.93
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature (1994) 3.70
Decoding cell death signals in inflammation and immunity. Cell (2010) 3.41
The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci (2002) 3.23
The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med (1991) 3.22
Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol (2004) 3.18
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med (1996) 2.99
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med (1992) 2.92
T cell defined tumor antigens. Curr Opin Immunol (1997) 2.90
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med (1995) 2.88
Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol (2006) 2.71
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci U S A (1995) 2.34
A unique tumor antigen produced by a single amino acid substitution. Immunity (1995) 2.33
Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B (1997) 2.25
Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol (2002) 2.18
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med (1998) 2.12
How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol (2005) 2.12
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta (2009) 2.07
The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J Exp Med (1997) 2.00
Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis (2003) 1.98
Molecular characteristics of immunogenic cancer cell death. Cell Death Differ (2007) 1.92
Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol (2002) 1.88
Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J Photochem Photobiol B (1992) 1.86
Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res (2009) 1.80
Immunotherapy for pancreatic cancer - science driving clinical progress. Nat Rev Cancer (2005) 1.74
RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med (2007) 1.66
Imbalance of regulatory T cells in human autoimmune diseases. Immunology (2006) 1.64
Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res (2006) 1.64
Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol (2006) 1.64
Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol (2004) 1.59
Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis (2009) 1.56
Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res (2007) 1.55
Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer (2003) 1.52
Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother (2009) 1.50
Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol (1992) 1.50
Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res (2005) 1.49
A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med (2003) 1.49
Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother (2002) 1.47
The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection. Eur J Immunol (1998) 1.43
Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol (2002) 1.42
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol (2003) 1.40
Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans. Br J Dermatol (2012) 1.39
The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res (1996) 1.35
PDT-associated host response and its role in the therapy outcome. Lasers Surg Med (2006) 1.35
Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J Immunol (2004) 1.33
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer (2003) 1.32
Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer (1995) 1.29
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol (2007) 1.29
Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res (1996) 1.28
Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res (1996) 1.28
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res (2001) 1.26
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A (2008) 1.23
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis (2010) 1.22
Vascular effects of photodynamic therapy. Anticancer Res (2002) 1.21
DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochem Photobiol Sci (2011) 1.20
Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res (1999) 1.19
Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol (1976) 1.18
In vitro effects of photodynamic therapy on Aspergillus fumigatus. J Antimicrob Chemother (2001) 1.18
Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett (2002) 1.15
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer (2007) 1.14
Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett (1999) 1.14
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res (2009) 1.14
Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob Agents Chemother (2005) 1.12
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One (2010) 1.12
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem Photobiol Sci (2002) 1.10
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res (2004) 1.09
Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst (1990) 1.09
Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol (2003) 1.07
Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy. Cancer Res (2002) 1.05
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation (2004) 1.02
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs (1994) 1.01
Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res (1997) 0.99
Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res (1997) 0.98
Photodynamic treatment of the dermatophyte Trichophyton rubrum and its microconidia with porphyrin photosensitizers. Photochem Photobiol (2004) 0.98
A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br J Cancer (2006) 0.97
Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit Rev Immunol (2009) 0.97
Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother (2005) 0.96
Immunomodulatory aspects of photodynamic therapy. Expert Opin Investig Drugs (1998) 0.95
Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol (2006) 0.94
Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci (2010) 0.94
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother (2008) 0.93